These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20030437)

  • 1. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
    Davies AJ; Kalson NS; Stokes S; Earl MD; Whitehead AG; Frost H; Tyrell-Marsh I; Naylor J
    Wilderness Environ Med; 2009; 20(4):311-7. PubMed ID: 20030437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mt. Whitney: determinants of summit success and acute mountain sickness.
    Wagner DR; D'Zatko K; Tatsugawa K; Murray K; Parker D; Streeper T; Willard K
    Med Sci Sports Exerc; 2008 Oct; 40(10):1820-7. PubMed ID: 18799993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Determinants of Acute Mountain Sickness and Summit Success on a 6-Day Ascent of Mount Kilimanjaro (5895 m).
    Lawrence JS; Reid SA
    Wilderness Environ Med; 2016 Mar; 27(1):78-84. PubMed ID: 26948557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-daily assessment of trekkers on Kilimanjaro's Machame route to evaluate the incidence and time-course of acute mountain sickness.
    Meyer J
    High Alt Med Biol; 2012 Dec; 13(4):281-4. PubMed ID: 23270446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute mountain sickness in Jade Mountain climbers of Taiwan.
    Kao WF; Kuo CC; Hsu TF; Chang H; Sung YY; Yen DH; Wu JK; Lee CH
    Aviat Space Environ Med; 2002 Apr; 73(4):359-62. PubMed ID: 11952056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.
    Vardy J; Vardy J; Judge K
    Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas.
    Basnyat B; Lemaster J; Litch JA
    Aviat Space Environ Med; 1999 Sep; 70(9):867-73. PubMed ID: 10503751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in oxygen saturation does not predict acute mountain sickness on Jade Mountain.
    Chen HC; Lin WL; Wu JY; Wang SH; Chiu TF; Weng YM; Hsu TY; Wu MH
    Wilderness Environ Med; 2012 Jun; 23(2):122-7. PubMed ID: 22656657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
    Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different duration of high-altitude pre-exposure associated with the incidence of acute mountain sickness on Jade Mountain.
    Weng YM; Chiu YH; Lynn JJ; Li WC; Wang SH; Kao WF; Hsu TY; Chiu TF; Lin YJ; Chan CW
    Am J Emerg Med; 2013 Jul; 31(7):1113-7. PubMed ID: 23688567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
    Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
    Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro.
    Jackson SJ; Varley J; Sellers C; Josephs K; Codrington L; Duke G; Njelekela MA; Drummond G; Sutherland AI; Thompson AA; Baillie JK
    High Alt Med Biol; 2010; 11(3):217-22. PubMed ID: 20919888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oximetry fails to predict acute mountain sickness or summit success during a rapid ascent to 5640 meters.
    Wagner DR; Knott JR; Fry JP
    Wilderness Environ Med; 2012 Jun; 23(2):114-21. PubMed ID: 22656656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up.
    McDevitt M; McIntosh SE; Rodway G; Peelay J; Adams DL; Kayser B
    Wilderness Environ Med; 2014 Jun; 25(2):152-9. PubMed ID: 24864065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can knowledge protect against acute mountain sickness?
    Vardy J; Vardy J; Judge K
    J Public Health (Oxf); 2005 Dec; 27(4):366-70. PubMed ID: 16234261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up.
    Gaillard S; Dellasanta P; Loutan L; Kayser B
    High Alt Med Biol; 2004; 5(4):410-9. PubMed ID: 15671630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal.
    Newcomb L; Sherpa C; Nickol A; Windsor J
    Wilderness Environ Med; 2011 Sep; 22(3):197-201. PubMed ID: 21962045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
    Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
    Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of acute mountain sickness in UK Military Personnel on Mount Kenya.
    Hazlerigg A; Woods DR; Mellor AJ
    J R Army Med Corps; 2016 Dec; 162(6):465-469. PubMed ID: 26604255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
    Bernhard WN; Schalick LM; Delaney PA; Bernhard TM; Barnas GM
    Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.